Literature DB >> 16338360

Is this protein ubiquitinated?

Peter Kaiser1, Christian Tagwerker.   

Abstract

Covalent modification of proteins with ubiquitin plays an important role in a wide array of cellular processes (Hershko and Ciechanover, 1998; Pickart, 2004). For this reason an increasing number of investigators in diverse research fields are confronted with the question whether their favorite proteins are ubiquitinated. Experiments to demonstrate covalent modification with ubiquitin in vivo can be quite challenging because of low steady-state levels of the ubiquitinated forms caused by degradation by the 26S proteasome and/or highly active deubiquitinating enzymes (Dubs) that remove the ubiquitin units (Pickart and Cohen, 2004; Wilkinson and Hochstrasser, 1998). Several different methods to determine whether a particular protein is ubiquitinated have been developed (Beers and Callis, 1993; Ellison and Hochstrasser, 1991; Hochstrasser et al., 1991; Treier et al., 1994). Some of these assays were described in detail by Laney and Hochstrasser (2002). This chapter is focused on one experimental approach using expression of hexahistidine-tagged ubiquitin. It can be applied to most situations in which one suspects ubiquitination of a particular protein and has been successfully used in various organisms (Kaiser et al., 2000; Treier et al., 1994).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338360     DOI: 10.1016/S0076-6879(05)99016-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  18 in total

1.  Salt stress-induced disassembly of Arabidopsis cortical microtubule arrays involves 26S proteasome-dependent degradation of SPIRAL1.

Authors:  Songhu Wang; Jasmina Kurepa; Takashi Hashimoto; Jan A Smalle
Journal:  Plant Cell       Date:  2011-09-27       Impact factor: 11.277

2.  Yeast deubiquitinase Ubp3 interacts with the 26 S proteasome to facilitate Rad4 degradation.

Authors:  Peng Mao; Michael J Smerdon
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

3.  Degradation of the Saccharomyces cerevisiae mating-type regulator alpha1: genetic dissection of cis-determinants and trans-acting pathways.

Authors:  Christina E Nixon; Alexander J Wilcox; Jeffrey D Laney
Journal:  Genetics       Date:  2010-03-29       Impact factor: 4.562

4.  A transcriptional activator is part of an SCF ubiquitin ligase to control degradation of its cofactors.

Authors:  Ikram Ouni; Karin Flick; Peter Kaiser
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

5.  Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.

Authors:  Nicholas J Genovese; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

6.  Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.

Authors:  Saleemulla Mahammad; S N Prasanna Murthy; Alessandro Didonna; Boris Grin; Eitan Israeli; Rodolphe Perrot; Pascale Bomont; Jean-Pierre Julien; Edward Kuczmarski; Puneet Opal; Robert D Goldman
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

7.  Polyubiquitylation of histone H2B.

Authors:  Fuqiang Geng; William P Tansey
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

8.  The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits.

Authors:  Daniel Moreno; Mhairi C Towler; D Grahame Hardie; Erwin Knecht; Pascual Sanz
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

9.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11

Review 10.  Regulation of STAT signaling by acetylation.

Authors:  Shougang Zhuang
Journal:  Cell Signal       Date:  2013-05-22       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.